Trials in Ventura, California
Here are the top 10 medical studies for breast cancer in Ventura, California
Popular Filters
Phase 3 Trials
Antibody-Drug Conjugate
Dato-DXd for Breast Cancer
Recruiting2 awardsPhase 3
Los Angeles, California
This trial is testing a new drug called datopotamab deruxtecan to see if it helps patients with advanced breast cancer live longer or have a better quality of life compared to standard chemotherapy. Datopotamab deruxtecan has shown encouraging response rates and manageable toxicity in patients with advanced/metastatic triple-negative breast cancer.
Hormone Therapy
Giredestrant + Hormone Therapy for Early-Stage Breast Cancer
Recruiting2 awardsPhase 3
Santa Barbara, California
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Estrogen Receptor Antagonist
Abemaciclib + Fulvestrant for Breast Cancer
Recruiting1 awardPhase 3
Santa Monica, California
This trial is testing a combination of two drugs, abemaciclib and fulvestrant, for treating a specific type of breast cancer that has not responded to previous treatments. Abemaciclib is taken orally and is approved for treating certain types of breast cancer. The goal is to see if this combination can help stop the cancer from growing. The study may last several years, depending on how well the treatment works for each patient.
Monoclonal Antibodies
Tucatinib + Trastuzumab + Pertuzumab for Breast Cancer
Recruiting1 awardPhase 3
Santa Monica, California
This trial is testing to see if adding tucatinib to trastuzumab and pertuzumab will help people with HER2-positive breast cancer live longer without their disease getting worse.
Trials With No Placebo
Antibody-Drug Conjugate
Dato-DXd for Breast Cancer
Recruiting2 awardsPhase 3
Los Angeles, California
This trial is testing a new drug called datopotamab deruxtecan to see if it helps patients with advanced breast cancer live longer or have a better quality of life compared to standard chemotherapy. Datopotamab deruxtecan has shown encouraging response rates and manageable toxicity in patients with advanced/metastatic triple-negative breast cancer.
Tyrosine Kinase Inhibitor
BAY2927088 for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1 & 2
Duarte, California
This trial is testing a new drug called BAY2927088 for people with advanced lung cancer. The drug aims to block certain proteins that help cancer grow. Researchers want to find out how safe the drug is, the best dose to use, and how well it works in stopping cancer.
Monoclonal Antibodies
HMBD-002 + Pembrolizumab for Cancer
Recruiting1 awardPhase 1
Los Angeles, California
This trial is testing a new drug, HMBD-002, on patients with advanced solid tumors. The drug will be administered intravenously, and the trial will have two parts: dose escalation and dose expansion.
Checkpoint Inhibitor
TransCon IL-2 β/γ + Pembrolizumab/Chemotherapy for Solid Tumor Cancers
Recruiting1 awardPhase 1 & 2
Los Angeles, California
This trial is testing a new drug called TransCon IL-2 β/γ for adults with advanced or spreading solid tumors. The drug aims to boost the immune system to better fight cancer by slowly releasing a molecule that helps immune cells attack cancer cells. TransCon IL-2 β/γ is a new long-acting drug currently being evaluated.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.